SCHEMBL23743175

SCHEMBL23743175

CC(C)CCCCC(NC(=O)COCCOCCC(C)C)C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ NOD1 Q9Y239 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ C3AR1 Q16581 2/20 0.35
▸ GLP1R P43220 8/20 0.35
▸ NMT2 O60551 1/20 0.33
▸ NMT1 P30419 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ FOLH1 Q04609 1/20 0.32
▸ ALB P02768 1/20 0.31
▸ HPGDS O60760 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23743173 1.00 KDM4E (0.40) KDM4EHSD17B10NPC1MAPTRAB9A
SCHEMBL25664162 0.86 GLP1R (0.43) KDM4EHSD17B10NPC1MAPTRAB9A
SCHEMBL25595600 0.85 GLP1R (0.43) KDM4EHSD17B10NPC1MAPTRAB9A
SCHEMBL25595599 0.85 GLP1R (0.43) KDM4EHSD17B10NPC1MAPTRAB9A
SCHEMBL23743174 0.82 KDM4E (0.40) KDM4EHSD17B10NPC1MAPTRAB9A
SCHEMBL16093019 0.79 GLP1R (0.41) NOD1C3AR1GLP1RALB
SCHEMBL27105920 0.78 TDP1 (0.44) KDM4EHSD17B10NPC1MAPTRAB9A
SCHEMBL13599221 0.78 TDP1 (0.44) KDM4EHSD17B10NPC1MAPTRAB9A
SCHEMBL13599224 0.78 TDP1 (0.44) KDM4EHSD17B10NPC1MAPTRAB9A
SCHEMBL16093004 0.77 GLP1R (0.37) HSD17B10NOD1C3AR1GLP1RALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210244824-A1 POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS OHIO STATE INNOVATION FOUNDATION 2021-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210244824-A1 POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS LNPEP, PCNP, NASP KDM4E 4478/4885HSD17B10 4307/4885NPC1 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback